Quadrature Capital’s Select Medical SEM Stock Holding History

Quadrature Capital’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,475	Closed	-$220K	–	1447
2025 Q2	$220K	Buy	+14,475	New	+$226K	﹤0.01%	787
2024 Q2	–	Sell	-35,175	Closed	-$572K	–	1494
2024 Q1	$572K	Sell	35,175 -38,118	-52%	-$558K	0.01%	665
2023 Q4	$928K	Buy	73,293 +25,694	+54%	+$324K	0.02%	468
2023 Q3	$648K	Buy	+47,599	New	+$735K	0.01%	523
2022 Q1	–	Sell	-28,454	Closed	-$451K	–	956
2021 Q4	$451K	Buy	+28,454	New	+$486K	0.02%	398
2021 Q2	–	Sell	-28,805	Closed	-$530K	–	1198
2021 Q1	$530K	Buy	+28,805	New	+$472K	0.03%	452
2020 Q4	–	Sell	-27,953	Closed	-$314K	–	1043
2020 Q3	$314K	Buy	+27,953	New	+$275K	0.02%	562
2019 Q2	–	Sell	-22,777	Closed	-$173K	–	639
2019 Q1	$173K	Buy	+22,777	New	+$183K	0.01%	491

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quadrature Capital's SEM Position: Q3 2025 in Review

Quadrature Capital sold out of Select Medical (SEM) in Q3 2025, closing a stake of 14,475 shares — an estimated $220K sold.

Quadrature Capital first reported a position in SEM in Q1 2019 and held it in 8 quarters. The position peaked at $928K in Q4 2023. 268 funds tracked by Wall St. Rank hold SEM as of Q3 2025.

Quadrature Capital reported no remaining Select Medical position as of Q3 2025 after selling out during the quarter.
Quadrature Capital sold 14,475 Select Medical shares in Q3 2025, an estimated $220K.
Quadrature Capital first reported a position in Select Medical in Q1 2019 and held it in 8 quarters.
Quadrature Capital's Select Medical position peaked at $928K in Q4 2023.
268 funds tracked by Wall St. Rank held Select Medical as of Q3 2025.

Based on Quadrature Capital's 13F filing for Q3 2025, filed 13 Nov 2025.